|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1993-11-5
|
|
pubmed:abstractText |
A phase II study was conducted between June 1989 and February 1992 to evaluate the activity and toxicity of photodynamic therapy (PDT) with photofrin II in centrally located early-stage lung cancer and to determine the complete response (CR) rate as the primary end point.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1852-7
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8410109-Aged,
pubmed-meshheading:8410109-Bronchoscopy,
pubmed-meshheading:8410109-Carcinoma, Squamous Cell,
pubmed-meshheading:8410109-Dihematoporphyrin Ether,
pubmed-meshheading:8410109-Female,
pubmed-meshheading:8410109-Humans,
pubmed-meshheading:8410109-Laser Therapy,
pubmed-meshheading:8410109-Lung Neoplasms,
pubmed-meshheading:8410109-Male,
pubmed-meshheading:8410109-Middle Aged,
pubmed-meshheading:8410109-Photochemotherapy,
pubmed-meshheading:8410109-Prospective Studies,
pubmed-meshheading:8410109-Regression Analysis,
pubmed-meshheading:8410109-Treatment Outcome
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group.
|
|
pubmed:affiliation |
Department of Internal Medicine, National Kinki Central Hospital for Chest Diseases, Osaka, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
